Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedThe study is no longer recruiting participants, and the total number of participating locations has decreased due to site removals.SummaryDifference3%

- Check14 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page. This indicates a new build/update of the page, with no substantive content changes implied.SummaryDifference0.0%

- Check21 days agoChange DetectedThe study's external identifiers now include an NIH grant/contract entry for 2023, reflecting NIH funding attribution.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedInstead of the trial details, the page now displays a 500 error indicating the service is unavailable. This renders the TROPHY U-01 study record on ClinicalTrials.gov inaccessible until the issue is resolved.SummaryDifference20%

- Check50 days agoChange Detected- The page revision label changed from v3.6.3 to v3.6.4, indicating a small update to the version history; this does not modify content or functionality.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a new editorial update to the page in the system.SummaryDifference0.0%

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.